Search results
Results from the WOW.Com Content Network
The Behaviour and Personality Assessment in Dogs (Beteende och personlighetsbeskrivning hund), commonly abbreviated as BPH, is a behavioural assessment developed by the Swedish Kennel Club (SKK) in May 2012 [1] [2] that aims to accurately describe the personality of a dog irrespective of whether it is a working, pet or breeding dog.
Xanthochromia, from the Greek xanthos (ξανθός) "yellow" and chroma (χρώμα) "colour", is the yellowish appearance of cerebrospinal fluid that occurs several hours after bleeding into the subarachnoid space caused by certain medical conditions, most commonly subarachnoid hemorrhage. [1]
Froin's syndrome – coexistence of xanthochromia, high protein level and marked coagulation of cerebrospinal fluid (CSF). It is caused by meningeal irritation (e.g. during spinal meningitis) and CSF flow blockage by tumour mass or abscess. [1]
Shelters use temperament tests to help identify dogs with problem behaviors, including aggression, and to help increase the rate of successful adoptions. [11] For some, these tests are a way to determine if a dog should even be offered for adoption, or to whom they will restrict adoption of an individual dog (adult-only household or sanctuary only, versus family with children).
Visual examination of the specimen may provide information to the pathologist or the physician. For example, fluid drained from an abscess may appear cloudy, or cerebrospinal fluid obtained by lumbar puncture may exhibit xanthochromia, suggesting a bleed has occurred. Laboratory technologists may provide qualitative descriptions accordingly.
Canine cognitive dysfunction (CCD) is a disease prevalent in dogs that exhibit symptoms of dementia or Alzheimer's disease shown in humans. [1] CCD creates pathological changes in the brain that slow the mental functioning of dogs resulting in loss of memory, motor function, and learned behaviors from training early in life.
Despite similar symptoms and blood test results to Cushing's disease, evaluation of dogs with SARDS did not reveal any tumors in the pituitary or adrenal glands, [9] and recent work has indicated significant differences in the clinical and laboratory test parameters between the two diseases.
In July 2017, Embark worked with Cornell University to test more than 6,000 dogs of various breeds in order to identify the genetic mutation that causes blue eyes, which was the first research of its kind to be conducted on non-humans. Dog owners conducted DNA tests from Embark, completed online surveys, and Embark and Cornell analyzed the data.